22nd Century Group (NASDAQ:XXII – Get Free Report)‘s stock had its “market perform” rating reissued by TD Cowen in a research note issued to investors on Tuesday, Benzinga reports. Separately, Dawson James decreased their price target on 22nd Century Group from $15.00 to $10.00 in a research report on Tuesday, July 25th. Read Our Latest […]
22nd Century Group (NASDAQ:XXII – Free Report) had its price objective reduced by Dawson James from $67.50 to $15.00 in a research report released on Monday morning, The Fly reports. Separately, Alliance Global Partners dropped their price objective on shares of 22nd Century Group from $60.00 to $45.00 in a report on Friday, March 10th. […]
22nd Century Group (NASDAQ:XXII – Free Report) had its price target reduced by equities research analysts at Dawson James from $4.50 to $1.00 in a research report issued to clients and investors on Monday, The Fly reports. Dawson James’ price objective would indicate a potential upside of 161.30% from the company’s previous close. Separately, Alliance […]
AE Wealth Management LLC raised its position in shares of 22nd Century Group, Inc. (NASDAQ:XXII – Get Rating) by 362.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 50,748 shares of the biotechnology company’s stock after purchasing an additional 39,767 […]